Stock Track | Labcorp Soars 9.80% in Pre-market on Strong Q1 Earnings Beat and Raised 2026 Guidance

Stock Track04-30

Labcorp Holdings Inc's stock surged 9.80% in pre-market trading following the release of its first-quarter 2026 financial results that exceeded analyst expectations and an upward revision of its full-year outlook.

The company reported adjusted earnings per share of $4.25 for Q1 2026, beating consensus estimates of approximately $4.09 to $4.11 and representing a 10.6% increase from the same period last year. Revenue rose 5.8% year-over-year to $3.54 billion, also surpassing analyst forecasts of around $3.50 to $3.51 billion.

Labcorp raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $17.70 to $18.35 and revenue between $14.65 billion and $14.80 billion. The company cited organic growth, continued momentum across its Diagnostics and Central Laboratory businesses, and strategic initiatives including expansion in specialty diagnostics and new collaborations as drivers of its strong performance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment